nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—attention deficit hyperactivity disorder—Guanfacine—hypertension	0.167	0.697	CpDpCtD
Amphetamine—SLC6A2—hypertension	0.0884	0.441	CbGaD
Amphetamine—attention deficit hyperactivity disorder—Clonidine—hypertension	0.0727	0.303	CpDpCtD
Amphetamine—SLC6A3—hypertension	0.045	0.224	CbGaD
Amphetamine—SLC18A2—Reserpine—hypertension	0.0379	0.181	CbGbCtD
Amphetamine—SLC6A4—hypertension	0.0336	0.168	CbGaD
Amphetamine—DRD2—hypertension	0.0335	0.167	CbGaD
Amphetamine—Phenacemide—Guanfacine—hypertension	0.0248	0.126	CrCrCtD
Amphetamine—SLC6A2—Guanadrel—hypertension	0.024	0.115	CbGbCtD
Amphetamine—Lisdexamfetamine—Labetalol—hypertension	0.0191	0.0972	CrCrCtD
Amphetamine—Aspartame—Quinapril—hypertension	0.0187	0.0952	CrCrCtD
Amphetamine—SLC6A2—Guanethidine—hypertension	0.0182	0.0868	CbGbCtD
Amphetamine—Nateglinide—Trandolapril—hypertension	0.0162	0.0825	CrCrCtD
Amphetamine—Nateglinide—Enalapril—hypertension	0.0162	0.0825	CrCrCtD
Amphetamine—Aspartame—Trandolapril—hypertension	0.0154	0.0784	CrCrCtD
Amphetamine—Aspartame—Enalapril—hypertension	0.0154	0.0784	CrCrCtD
Amphetamine—SLC22A3—Prazosin—hypertension	0.0153	0.0728	CbGbCtD
Amphetamine—Lisdexamfetamine—Lisinopril—hypertension	0.0142	0.0724	CrCrCtD
Amphetamine—Nateglinide—Lisinopril—hypertension	0.0127	0.0646	CrCrCtD
Amphetamine—Nateglinide—Ramipril—hypertension	0.0123	0.0626	CrCrCtD
Amphetamine—Aspartame—Lisinopril—hypertension	0.0121	0.0613	CrCrCtD
Amphetamine—Aspartame—Ramipril—hypertension	0.0117	0.0594	CrCrCtD
Amphetamine—SLC22A3—Clonidine—hypertension	0.0116	0.0552	CbGbCtD
Amphetamine—DRD2—Fenoldopam—hypertension	0.00828	0.0395	CbGbCtD
Amphetamine—Benzphetamine—Bepridil—hypertension	0.00771	0.0393	CrCrCtD
Amphetamine—SLC22A5—Clonidine—hypertension	0.00718	0.0343	CbGbCtD
Amphetamine—CYP2A6—Amlodipine—hypertension	0.00678	0.0323	CbGbCtD
Amphetamine—CYP2A6—Nifedipine—hypertension	0.00632	0.0301	CbGbCtD
Amphetamine—SLC22A5—Furosemide—hypertension	0.00598	0.0285	CbGbCtD
Amphetamine—SLC6A2—Clonidine—hypertension	0.00573	0.0273	CbGbCtD
Amphetamine—SLC22A5—Verapamil—hypertension	0.00517	0.0246	CbGbCtD
Amphetamine—SLC6A4—Verapamil—hypertension	0.00493	0.0235	CbGbCtD
Amphetamine—CYP2D6—Nebivolol—hypertension	0.00414	0.0197	CbGbCtD
Amphetamine—CYP2D6—Labetalol—hypertension	0.00414	0.0197	CbGbCtD
Amphetamine—CYP2D6—Acebutolol—hypertension	0.00378	0.018	CbGbCtD
Amphetamine—CYP2D6—Metoprolol—hypertension	0.00352	0.0168	CbGbCtD
Amphetamine—CYP2D6—Pindolol—hypertension	0.00352	0.0168	CbGbCtD
Amphetamine—CYP2D6—Betaxolol—hypertension	0.00314	0.015	CbGbCtD
Amphetamine—CYP2D6—Doxazosin—hypertension	0.00276	0.0132	CbGbCtD
Amphetamine—CYP2D6—Diltiazem—hypertension	0.00267	0.0127	CbGbCtD
Amphetamine—CYP2D6—Bepridil—hypertension	0.00238	0.0113	CbGbCtD
Amphetamine—CYP2D6—Irbesartan—hypertension	0.00217	0.0104	CbGbCtD
Amphetamine—CYP2D6—Amlodipine—hypertension	0.00213	0.0102	CbGbCtD
Amphetamine—CYP2D6—Felodipine—hypertension	0.00206	0.0098	CbGbCtD
Amphetamine—CYP2D6—Timolol—hypertension	0.00202	0.00963	CbGbCtD
Amphetamine—CYP2D6—Nifedipine—hypertension	0.00199	0.00948	CbGbCtD
Amphetamine—CYP2D6—Nicardipine—hypertension	0.00196	0.00933	CbGbCtD
Amphetamine—CYP2D6—Carvedilol—hypertension	0.00196	0.00933	CbGbCtD
Amphetamine—CYP2D6—Propranolol—hypertension	0.0018	0.00859	CbGbCtD
Amphetamine—CYP2D6—Captopril—hypertension	0.00178	0.00848	CbGbCtD
Amphetamine—CYP2D6—Clonidine—hypertension	0.00172	0.00819	CbGbCtD
Amphetamine—CYP2D6—Atorvastatin—hypertension	0.00153	0.0073	CbGbCtD
Amphetamine—SLC6A2—locus ceruleus—hypertension	0.00146	0.091	CbGeAlD
Amphetamine—CYP2D6—Verapamil—hypertension	0.00124	0.00589	CbGbCtD
Amphetamine—SLC6A2—sympathetic nervous system—hypertension	0.00116	0.0719	CbGeAlD
Amphetamine—CARTPT—brainstem—hypertension	0.000904	0.0563	CbGeAlD
Amphetamine—CARTPT—adrenal cortex—hypertension	0.000809	0.0503	CbGeAlD
Amphetamine—SLC6A2—autonomic nervous system—hypertension	0.000777	0.0483	CbGeAlD
Amphetamine—CARTPT—medulla oblongata—hypertension	0.000631	0.0392	CbGeAlD
Amphetamine—CARTPT—adrenal gland—hypertension	0.000584	0.0363	CbGeAlD
Amphetamine—CARTPT—endocrine gland—hypertension	0.000506	0.0315	CbGeAlD
Amphetamine—CARTPT—central nervous system—hypertension	0.000456	0.0284	CbGeAlD
Amphetamine—TAAR1—central nervous system—hypertension	0.000456	0.0284	CbGeAlD
Amphetamine—CYP2D6—urine—hypertension	0.000347	0.0216	CbGeAlD
Amphetamine—SLC18A2—brainstem—hypertension	0.000307	0.0191	CbGeAlD
Amphetamine—MAOB—cardiac ventricle—hypertension	0.000267	0.0166	CbGeAlD
Amphetamine—MAOB—myocardium—hypertension	0.000251	0.0156	CbGeAlD
Amphetamine—SLC6A3—brainstem—hypertension	0.000232	0.0145	CbGeAlD
Amphetamine—Bethanidine—KCNJ1—hypertension	0.000226	0.0968	CrCbGaD
Amphetamine—SLC18A2—medulla oblongata—hypertension	0.000214	0.0133	CbGeAlD
Amphetamine—SLC6A4—brainstem—hypertension	0.000213	0.0133	CbGeAlD
Amphetamine—SLC22A5—cardiac ventricle—hypertension	0.00021	0.013	CbGeAlD
Amphetamine—MAOB—brainstem—hypertension	0.000203	0.0126	CbGeAlD
Amphetamine—SLC18A2—adrenal gland—hypertension	0.000198	0.0123	CbGeAlD
Amphetamine—SLC22A5—myocardium—hypertension	0.000197	0.0123	CbGeAlD
Amphetamine—SLC22A3—smooth muscle tissue—hypertension	0.000188	0.0117	CbGeAlD
Amphetamine—SLC6A2—brainstem—hypertension	0.000188	0.0117	CbGeAlD
Amphetamine—MAOB—nephron tubule—hypertension	0.000184	0.0115	CbGeAlD
Amphetamine—MAOB—adrenal cortex—hypertension	0.000181	0.0113	CbGeAlD
Amphetamine—MAOB—heart—hypertension	0.000175	0.0109	CbGeAlD
Amphetamine—SLC22A3—kidney—hypertension	0.000175	0.0109	CbGeAlD
Amphetamine—SLC18A2—endocrine gland—hypertension	0.000172	0.0107	CbGeAlD
Amphetamine—DRD2—brainstem—hypertension	0.000171	0.0106	CbGeAlD
Amphetamine—MAOB—decidua—hypertension	0.00017	0.0106	CbGeAlD
Amphetamine—MAOB—cardiovascular system—hypertension	0.000165	0.0103	CbGeAlD
Amphetamine—MAOB—kidney—hypertension	0.000162	0.0101	CbGeAlD
Amphetamine—SLC6A2—decidua—hypertension	0.000158	0.00982	CbGeAlD
Amphetamine—MAOB—cortex of kidney—hypertension	0.000158	0.0098	CbGeAlD
Amphetamine—SLC18A2—central nervous system—hypertension	0.000155	0.00965	CbGeAlD
Amphetamine—Phenformin—KCNJ8—hypertension	0.000155	0.0662	CrCbGaD
Amphetamine—MAOB—cardiac atrium—hypertension	0.00015	0.00932	CbGeAlD
Amphetamine—SLC22A5—nephron tubule—hypertension	0.000145	0.009	CbGeAlD
Amphetamine—SLC22A5—adrenal cortex—hypertension	0.000142	0.00886	CbGeAlD
Amphetamine—SLC22A3—adrenal gland—hypertension	0.000141	0.00879	CbGeAlD
Amphetamine—MAOB—medulla oblongata—hypertension	0.000141	0.00879	CbGeAlD
Amphetamine—SLC22A5—heart—hypertension	0.000138	0.00857	CbGeAlD
Amphetamine—SLC6A2—medulla oblongata—hypertension	0.000131	0.00814	CbGeAlD
Amphetamine—MAOB—adrenal gland—hypertension	0.000131	0.00814	CbGeAlD
Amphetamine—SLC22A5—kidney—hypertension	0.000127	0.00791	CbGeAlD
Amphetamine—SLC22A5—cortex of kidney—hypertension	0.000124	0.0077	CbGeAlD
Amphetamine—SLC22A3—endocrine gland—hypertension	0.000123	0.00762	CbGeAlD
Amphetamine—SLC6A2—adrenal gland—hypertension	0.000121	0.00753	CbGeAlD
Amphetamine—SLC6A4—endocrine gland—hypertension	0.000119	0.00742	CbGeAlD
Amphetamine—SLC22A5—cardiac atrium—hypertension	0.000118	0.00733	CbGeAlD
Amphetamine—SLC6A3—central nervous system—hypertension	0.000117	0.0073	CbGeAlD
Amphetamine—MAOB—endocrine gland—hypertension	0.000113	0.00706	CbGeAlD
Amphetamine—SLC22A5—medulla oblongata—hypertension	0.000111	0.00691	CbGeAlD
Amphetamine—SLC22A3—central nervous system—hypertension	0.00011	0.00687	CbGeAlD
Amphetamine—SLC6A4—central nervous system—hypertension	0.000107	0.00669	CbGeAlD
Amphetamine—Diethylpropion—SLC6A2—hypertension	0.000105	0.0452	CrCbGaD
Amphetamine—SLC6A2—endocrine gland—hypertension	0.000105	0.00653	CbGeAlD
Amphetamine—SLC22A5—adrenal gland—hypertension	0.000103	0.00639	CbGeAlD
Amphetamine—CYP2D6—brainstem—hypertension	0.000103	0.00639	CbGeAlD
Amphetamine—MAOB—central nervous system—hypertension	0.000102	0.00636	CbGeAlD
Amphetamine—DRD2—endocrine gland—hypertension	9.57e-05	0.00595	CbGeAlD
Amphetamine—SLC6A2—central nervous system—hypertension	9.46e-05	0.00589	CbGeAlD
Amphetamine—Bethanidine—SLC6A2—hypertension	9.26e-05	0.0397	CrCbGaD
Amphetamine—DRD2—central nervous system—hypertension	8.62e-05	0.00536	CbGeAlD
Amphetamine—Mephentermine—ADRA1A—hypertension	8.42e-05	0.0361	CrCbGaD
Amphetamine—CYP2D6—kidney—hypertension	8.2e-05	0.0051	CbGeAlD
Amphetamine—Lisdexamfetamine—SLC6A2—hypertension	7.99e-05	0.0343	CrCbGaD
Amphetamine—Phenelzine—ABAT—hypertension	7.33e-05	0.0314	CrCbGaD
Amphetamine—Tolazoline—ADRA2B—hypertension	7.3e-05	0.0313	CrCbGaD
Amphetamine—Ephedrine—SLC6A2—hypertension	6.25e-05	0.0268	CrCbGaD
Amphetamine—Benzyl alcohol—ALDH2—hypertension	6.1e-05	0.0262	CrCbGaD
Amphetamine—CYP2D6—endocrine gland—hypertension	5.75e-05	0.00358	CbGeAlD
Amphetamine—Phenylpropanolamine—SLC6A2—hypertension	5.61e-05	0.024	CrCbGaD
Amphetamine—L-Phenylalanine—TH—hypertension	5.52e-05	0.0237	CrCbGaD
Amphetamine—Diethylpropion—SLC6A3—hypertension	5.36e-05	0.023	CrCbGaD
Amphetamine—CYP2D6—central nervous system—hypertension	5.18e-05	0.00322	CbGeAlD
Amphetamine—Phentermine—SLC6A2—hypertension	5e-05	0.0214	CrCbGaD
Amphetamine—Dextroamphetamine—SLC6A2—hypertension	4.77e-05	0.0204	CrCbGaD
Amphetamine—Pseudoephedrine—SLC6A2—hypertension	4.74e-05	0.0203	CrCbGaD
Amphetamine—Tolazoline—ADRA1A—hypertension	4.52e-05	0.0194	CrCbGaD
Amphetamine—Ephedrine—ADRA1A—hypertension	4.41e-05	0.0189	CrCbGaD
Amphetamine—Lisdexamfetamine—SLC6A3—hypertension	4.07e-05	0.0174	CrCbGaD
Amphetamine—Methamphetamine—ADRA2B—hypertension	4.05e-05	0.0174	CrCbGaD
Amphetamine—Nateglinide—KCNJ11—hypertension	3.97e-05	0.017	CrCbGaD
Amphetamine—Phenylpropanolamine—ADRA1A—hypertension	3.95e-05	0.0169	CrCbGaD
Amphetamine—Lacosamide—CA9—hypertension	3.91e-05	0.0167	CrCbGaD
Amphetamine—Methamphetamine—SLC6A2—hypertension	3.56e-05	0.0153	CrCbGaD
Amphetamine—Benzphetamine—SLC6A2—hypertension	3.53e-05	0.0151	CrCbGaD
Amphetamine—Dextroamphetamine—ADRA1A—hypertension	3.36e-05	0.0144	CrCbGaD
Amphetamine—Pseudoephedrine—ADRA1A—hypertension	3.34e-05	0.0143	CrCbGaD
Amphetamine—Tolazoline—ADRA2A—hypertension	3.2e-05	0.0137	CrCbGaD
Amphetamine—Phenylpropanolamine—SLC6A3—hypertension	2.85e-05	0.0122	CrCbGaD
Amphetamine—Phenylpropanolamine—ADRA2A—hypertension	2.8e-05	0.012	CrCbGaD
Amphetamine—Phenylpropanolamine—ADRB1—hypertension	2.79e-05	0.012	CrCbGaD
Amphetamine—Ephedrine—ADRB2—hypertension	2.62e-05	0.0112	CrCbGaD
Amphetamine—Phentermine—SLC6A3—hypertension	2.54e-05	0.0109	CrCbGaD
Amphetamine—Benzphetamine—ADRA1A—hypertension	2.49e-05	0.0107	CrCbGaD
Amphetamine—Dextroamphetamine—SLC6A3—hypertension	2.43e-05	0.0104	CrCbGaD
Amphetamine—Pseudoephedrine—SLC6A3—hypertension	2.41e-05	0.0103	CrCbGaD
Amphetamine—Pseudoephedrine—ADRA2A—hypertension	2.36e-05	0.0101	CrCbGaD
Amphetamine—Pseudoephedrine—ADRB1—hypertension	2.36e-05	0.0101	CrCbGaD
Amphetamine—Phenylpropanolamine—ADRB2—hypertension	2.35e-05	0.0101	CrCbGaD
Amphetamine—Pseudoephedrine—TNF—hypertension	2.24e-05	0.0096	CrCbGaD
Amphetamine—Nateglinide—PPARG—hypertension	2.2e-05	0.00943	CrCbGaD
Amphetamine—Nateglinide—CYP3A5—hypertension	2.19e-05	0.00939	CrCbGaD
Amphetamine—Phenelzine—CYP3A5—hypertension	2.16e-05	0.00926	CrCbGaD
Amphetamine—Pseudoephedrine—ADRB2—hypertension	1.99e-05	0.00851	CrCbGaD
Amphetamine—Dermatitis—Carvedilol—hypertension	1.96e-05	0.000236	CcSEcCtD
Amphetamine—Anxiety—Timolol—hypertension	1.96e-05	0.000235	CcSEcCtD
Amphetamine—Angioedema—Lisinopril—hypertension	1.96e-05	0.000235	CcSEcCtD
Amphetamine—Vomiting—Doxazosin—hypertension	1.96e-05	0.000235	CcSEcCtD
Amphetamine—Decreased appetite—Losartan—hypertension	1.96e-05	0.000235	CcSEcCtD
Amphetamine—Gastrointestinal pain—Irbesartan—hypertension	1.96e-05	0.000235	CcSEcCtD
Amphetamine—Hypersensitivity—Clonidine—hypertension	1.96e-05	0.000235	CcSEcCtD
Amphetamine—Body temperature increased—Captopril—hypertension	1.95e-05	0.000235	CcSEcCtD
Amphetamine—Abdominal pain—Captopril—hypertension	1.95e-05	0.000235	CcSEcCtD
Amphetamine—Headache—Carvedilol—hypertension	1.95e-05	0.000234	CcSEcCtD
Amphetamine—Rash—Doxazosin—hypertension	1.94e-05	0.000233	CcSEcCtD
Amphetamine—Fatigue—Losartan—hypertension	1.94e-05	0.000233	CcSEcCtD
Amphetamine—Dermatitis—Doxazosin—hypertension	1.94e-05	0.000233	CcSEcCtD
Amphetamine—Gastrointestinal pain—Hydrochlorothiazide—hypertension	1.94e-05	0.000233	CcSEcCtD
Amphetamine—Vomiting—Fosinopril—hypertension	1.94e-05	0.000232	CcSEcCtD
Amphetamine—Nausea—Propranolol—hypertension	1.93e-05	0.000232	CcSEcCtD
Amphetamine—Anaphylactic shock—Ramipril—hypertension	1.93e-05	0.000232	CcSEcCtD
Amphetamine—Headache—Doxazosin—hypertension	1.93e-05	0.000232	CcSEcCtD
Amphetamine—Dry mouth—Timolol—hypertension	1.93e-05	0.000231	CcSEcCtD
Amphetamine—Constipation—Losartan—hypertension	1.93e-05	0.000231	CcSEcCtD
Amphetamine—Vomiting—Eplerenone—hypertension	1.92e-05	0.000231	CcSEcCtD
Amphetamine—Rash—Fosinopril—hypertension	1.92e-05	0.00023	CcSEcCtD
Amphetamine—Dermatitis—Fosinopril—hypertension	1.92e-05	0.00023	CcSEcCtD
Amphetamine—Vomiting—Nifedipine—hypertension	1.91e-05	0.000229	CcSEcCtD
Amphetamine—Gastrointestinal pain—Furosemide—hypertension	1.91e-05	0.000229	CcSEcCtD
Amphetamine—Rash—Eplerenone—hypertension	1.91e-05	0.000229	CcSEcCtD
Amphetamine—Urticaria—Perindopril—hypertension	1.91e-05	0.000229	CcSEcCtD
Amphetamine—Headache—Fosinopril—hypertension	1.91e-05	0.000229	CcSEcCtD
Amphetamine—Hypersensitivity—Trandolapril—hypertension	1.91e-05	0.000229	CcSEcCtD
Amphetamine—Dermatitis—Eplerenone—hypertension	1.91e-05	0.000229	CcSEcCtD
Amphetamine—Diarrhoea—Valsartan—hypertension	1.91e-05	0.000229	CcSEcCtD
Amphetamine—Asthenia—Clonidine—hypertension	1.9e-05	0.000228	CcSEcCtD
Amphetamine—Phentermine—SLC6A4—hypertension	1.9e-05	0.00815	CrCbGaD
Amphetamine—Vomiting—Verapamil—hypertension	1.9e-05	0.000228	CcSEcCtD
Amphetamine—Urticaria—Irbesartan—hypertension	1.9e-05	0.000228	CcSEcCtD
Amphetamine—Hypersensitivity—Enalapril—hypertension	1.9e-05	0.000228	CcSEcCtD
Amphetamine—Abdominal pain—Perindopril—hypertension	1.9e-05	0.000228	CcSEcCtD
Amphetamine—Body temperature increased—Perindopril—hypertension	1.9e-05	0.000228	CcSEcCtD
Amphetamine—Palpitations—Lisinopril—hypertension	1.9e-05	0.000227	CcSEcCtD
Amphetamine—Diarrhoea—Olmesartan—hypertension	1.9e-05	0.000227	CcSEcCtD
Amphetamine—Headache—Eplerenone—hypertension	1.9e-05	0.000227	CcSEcCtD
Amphetamine—Rash—Nifedipine—hypertension	1.89e-05	0.000227	CcSEcCtD
Amphetamine—Dermatitis—Nifedipine—hypertension	1.89e-05	0.000227	CcSEcCtD
Amphetamine—Abdominal pain—Irbesartan—hypertension	1.89e-05	0.000227	CcSEcCtD
Amphetamine—Body temperature increased—Irbesartan—hypertension	1.89e-05	0.000227	CcSEcCtD
Amphetamine—Anaphylactic shock—Timolol—hypertension	1.89e-05	0.000226	CcSEcCtD
Amphetamine—Rash—Verapamil—hypertension	1.89e-05	0.000226	CcSEcCtD
Amphetamine—Urticaria—Hydrochlorothiazide—hypertension	1.89e-05	0.000226	CcSEcCtD
Amphetamine—Tachycardia—Ramipril—hypertension	1.88e-05	0.000226	CcSEcCtD
Amphetamine—Dermatitis—Verapamil—hypertension	1.88e-05	0.000226	CcSEcCtD
Amphetamine—Headache—Nifedipine—hypertension	1.88e-05	0.000226	CcSEcCtD
Amphetamine—Body temperature increased—Hydrochlorothiazide—hypertension	1.88e-05	0.000225	CcSEcCtD
Amphetamine—Abdominal pain—Hydrochlorothiazide—hypertension	1.88e-05	0.000225	CcSEcCtD
Amphetamine—Infection—Timolol—hypertension	1.88e-05	0.000225	CcSEcCtD
Amphetamine—Headache—Verapamil—hypertension	1.87e-05	0.000225	CcSEcCtD
Amphetamine—Hypersensitivity—Telmisartan—hypertension	1.87e-05	0.000225	CcSEcCtD
Amphetamine—Nausea—Diltiazem—hypertension	1.87e-05	0.000224	CcSEcCtD
Amphetamine—Nausea—Indapamide—hypertension	1.87e-05	0.000224	CcSEcCtD
Amphetamine—Hyperhidrosis—Ramipril—hypertension	1.87e-05	0.000224	CcSEcCtD
Amphetamine—Asthenia—Trandolapril—hypertension	1.86e-05	0.000223	CcSEcCtD
Amphetamine—Urticaria—Furosemide—hypertension	1.85e-05	0.000222	CcSEcCtD
Amphetamine—Nausea—Carvedilol—hypertension	1.85e-05	0.000222	CcSEcCtD
Amphetamine—Asthenia—Enalapril—hypertension	1.85e-05	0.000222	CcSEcCtD
Amphetamine—Body temperature increased—Furosemide—hypertension	1.85e-05	0.000221	CcSEcCtD
Amphetamine—Abdominal pain—Furosemide—hypertension	1.85e-05	0.000221	CcSEcCtD
Amphetamine—Gastrointestinal pain—Losartan—hypertension	1.84e-05	0.000221	CcSEcCtD
Amphetamine—Dizziness—Valsartan—hypertension	1.84e-05	0.000221	CcSEcCtD
Amphetamine—Anorexia—Ramipril—hypertension	1.84e-05	0.000221	CcSEcCtD
Amphetamine—Urticaria—Betaxolol—hypertension	1.84e-05	0.00022	CcSEcCtD
Amphetamine—Dizziness—Olmesartan—hypertension	1.83e-05	0.00022	CcSEcCtD
Amphetamine—Nausea—Doxazosin—hypertension	1.83e-05	0.00022	CcSEcCtD
Amphetamine—Chest pain—Lisinopril—hypertension	1.83e-05	0.000219	CcSEcCtD
Amphetamine—Body temperature increased—Betaxolol—hypertension	1.83e-05	0.000219	CcSEcCtD
Amphetamine—Hyperhidrosis—Timolol—hypertension	1.83e-05	0.000219	CcSEcCtD
Amphetamine—Asthenia—Telmisartan—hypertension	1.82e-05	0.000219	CcSEcCtD
Amphetamine—Anxiety—Lisinopril—hypertension	1.82e-05	0.000218	CcSEcCtD
Amphetamine—Diarrhoea—Clonidine—hypertension	1.82e-05	0.000218	CcSEcCtD
Amphetamine—Methamphetamine—SLC6A3—hypertension	1.81e-05	0.00777	CrCbGaD
Amphetamine—Nausea—Fosinopril—hypertension	1.81e-05	0.000217	CcSEcCtD
Amphetamine—Pseudoephedrine—SLC6A4—hypertension	1.8e-05	0.00773	CrCbGaD
Amphetamine—Anorexia—Timolol—hypertension	1.8e-05	0.000216	CcSEcCtD
Amphetamine—Nausea—Eplerenone—hypertension	1.8e-05	0.000216	CcSEcCtD
Amphetamine—Benzphetamine—SLC6A3—hypertension	1.8e-05	0.00771	CrCbGaD
Amphetamine—Urticaria—Losartan—hypertension	1.79e-05	0.000215	CcSEcCtD
Amphetamine—Dry mouth—Lisinopril—hypertension	1.79e-05	0.000214	CcSEcCtD
Amphetamine—Nausea—Nifedipine—hypertension	1.78e-05	0.000214	CcSEcCtD
Amphetamine—Abdominal pain—Losartan—hypertension	1.78e-05	0.000214	CcSEcCtD
Amphetamine—Body temperature increased—Losartan—hypertension	1.78e-05	0.000214	CcSEcCtD
Amphetamine—Nausea—Verapamil—hypertension	1.78e-05	0.000213	CcSEcCtD
Amphetamine—Methamphetamine—ADRA2A—hypertension	1.78e-05	0.00762	CrCbGaD
Amphetamine—Asthenia—Captopril—hypertension	1.77e-05	0.000213	CcSEcCtD
Amphetamine—Diarrhoea—Trandolapril—hypertension	1.77e-05	0.000212	CcSEcCtD
Amphetamine—Vomiting—Valsartan—hypertension	1.77e-05	0.000212	CcSEcCtD
Amphetamine—Diarrhoea—Enalapril—hypertension	1.76e-05	0.000212	CcSEcCtD
Amphetamine—Hypersensitivity—Irbesartan—hypertension	1.76e-05	0.000212	CcSEcCtD
Amphetamine—Benzphetamine—ADRA2A—hypertension	1.76e-05	0.00755	CrCbGaD
Amphetamine—Vomiting—Olmesartan—hypertension	1.76e-05	0.000211	CcSEcCtD
Amphetamine—Rash—Valsartan—hypertension	1.76e-05	0.000211	CcSEcCtD
Amphetamine—Dizziness—Clonidine—hypertension	1.76e-05	0.000211	CcSEcCtD
Amphetamine—Dermatitis—Valsartan—hypertension	1.75e-05	0.00021	CcSEcCtD
Amphetamine—Anaphylactic shock—Lisinopril—hypertension	1.75e-05	0.00021	CcSEcCtD
Amphetamine—Hypersensitivity—Hydrochlorothiazide—hypertension	1.75e-05	0.00021	CcSEcCtD
Amphetamine—Rash—Olmesartan—hypertension	1.75e-05	0.00021	CcSEcCtD
Amphetamine—Insomnia—Ramipril—hypertension	1.75e-05	0.00021	CcSEcCtD
Amphetamine—Dermatitis—Olmesartan—hypertension	1.75e-05	0.000209	CcSEcCtD
Amphetamine—Headache—Valsartan—hypertension	1.74e-05	0.000209	CcSEcCtD
Amphetamine—Diarrhoea—Telmisartan—hypertension	1.74e-05	0.000209	CcSEcCtD
Amphetamine—Infection—Lisinopril—hypertension	1.74e-05	0.000209	CcSEcCtD
Amphetamine—Headache—Olmesartan—hypertension	1.74e-05	0.000208	CcSEcCtD
Amphetamine—Benzyl alcohol—CYP1A1—hypertension	1.73e-05	0.00742	CrCbGaD
Amphetamine—Asthenia—Perindopril—hypertension	1.72e-05	0.000207	CcSEcCtD
Amphetamine—Dyspnoea—Ramipril—hypertension	1.72e-05	0.000207	CcSEcCtD
Amphetamine—Hypersensitivity—Furosemide—hypertension	1.72e-05	0.000206	CcSEcCtD
Amphetamine—Asthenia—Irbesartan—hypertension	1.72e-05	0.000206	CcSEcCtD
Amphetamine—Somnolence—Ramipril—hypertension	1.72e-05	0.000206	CcSEcCtD
Amphetamine—Dizziness—Trandolapril—hypertension	1.71e-05	0.000205	CcSEcCtD
Amphetamine—Tachycardia—Lisinopril—hypertension	1.71e-05	0.000205	CcSEcCtD
Amphetamine—Insomnia—Timolol—hypertension	1.71e-05	0.000205	CcSEcCtD
Amphetamine—Dizziness—Enalapril—hypertension	1.71e-05	0.000205	CcSEcCtD
Amphetamine—Asthenia—Hydrochlorothiazide—hypertension	1.7e-05	0.000204	CcSEcCtD
Amphetamine—Hypersensitivity—Betaxolol—hypertension	1.7e-05	0.000204	CcSEcCtD
Amphetamine—Dyspepsia—Ramipril—hypertension	1.7e-05	0.000204	CcSEcCtD
Amphetamine—Hyperhidrosis—Lisinopril—hypertension	1.69e-05	0.000203	CcSEcCtD
Amphetamine—Diarrhoea—Captopril—hypertension	1.69e-05	0.000203	CcSEcCtD
Amphetamine—Vomiting—Clonidine—hypertension	1.69e-05	0.000202	CcSEcCtD
Amphetamine—Dyspnoea—Timolol—hypertension	1.68e-05	0.000202	CcSEcCtD
Amphetamine—Dizziness—Telmisartan—hypertension	1.68e-05	0.000202	CcSEcCtD
Amphetamine—Decreased appetite—Ramipril—hypertension	1.68e-05	0.000201	CcSEcCtD
Amphetamine—Somnolence—Timolol—hypertension	1.68e-05	0.000201	CcSEcCtD
Amphetamine—Asthenia—Furosemide—hypertension	1.67e-05	0.000201	CcSEcCtD
Amphetamine—Rash—Clonidine—hypertension	1.67e-05	0.000201	CcSEcCtD
Amphetamine—Dermatitis—Clonidine—hypertension	1.67e-05	0.000201	CcSEcCtD
Amphetamine—Anorexia—Lisinopril—hypertension	1.67e-05	0.0002	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Ramipril—hypertension	1.67e-05	0.0002	CcSEcCtD
Amphetamine—Fatigue—Ramipril—hypertension	1.66e-05	0.0002	CcSEcCtD
Amphetamine—Headache—Clonidine—hypertension	1.66e-05	0.000199	CcSEcCtD
Amphetamine—Dyspepsia—Timolol—hypertension	1.66e-05	0.000199	CcSEcCtD
Amphetamine—Hypersensitivity—Losartan—hypertension	1.66e-05	0.000199	CcSEcCtD
Amphetamine—Asthenia—Betaxolol—hypertension	1.66e-05	0.000199	CcSEcCtD
Amphetamine—Nausea—Valsartan—hypertension	1.65e-05	0.000198	CcSEcCtD
Amphetamine—Constipation—Ramipril—hypertension	1.65e-05	0.000198	CcSEcCtD
Amphetamine—Nausea—Olmesartan—hypertension	1.65e-05	0.000197	CcSEcCtD
Amphetamine—Vomiting—Trandolapril—hypertension	1.65e-05	0.000197	CcSEcCtD
Amphetamine—Diarrhoea—Perindopril—hypertension	1.64e-05	0.000197	CcSEcCtD
Amphetamine—Decreased appetite—Timolol—hypertension	1.64e-05	0.000197	CcSEcCtD
Amphetamine—Vomiting—Enalapril—hypertension	1.64e-05	0.000197	CcSEcCtD
Amphetamine—Diarrhoea—Irbesartan—hypertension	1.64e-05	0.000196	CcSEcCtD
Amphetamine—Dizziness—Captopril—hypertension	1.64e-05	0.000196	CcSEcCtD
Amphetamine—Rash—Trandolapril—hypertension	1.63e-05	0.000196	CcSEcCtD
Amphetamine—Dermatitis—Trandolapril—hypertension	1.63e-05	0.000196	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Timolol—hypertension	1.63e-05	0.000196	CcSEcCtD
Amphetamine—Fatigue—Timolol—hypertension	1.63e-05	0.000195	CcSEcCtD
Amphetamine—Rash—Enalapril—hypertension	1.63e-05	0.000195	CcSEcCtD
Amphetamine—Dermatitis—Enalapril—hypertension	1.62e-05	0.000195	CcSEcCtD
Amphetamine—Nateglinide—PTGS1—hypertension	1.62e-05	0.00696	CrCbGaD
Amphetamine—Diarrhoea—Hydrochlorothiazide—hypertension	1.62e-05	0.000195	CcSEcCtD
Amphetamine—Headache—Trandolapril—hypertension	1.62e-05	0.000195	CcSEcCtD
Amphetamine—Vomiting—Telmisartan—hypertension	1.62e-05	0.000194	CcSEcCtD
Amphetamine—Asthenia—Losartan—hypertension	1.62e-05	0.000194	CcSEcCtD
Amphetamine—Headache—Enalapril—hypertension	1.62e-05	0.000194	CcSEcCtD
Amphetamine—Rash—Telmisartan—hypertension	1.6e-05	0.000192	CcSEcCtD
Amphetamine—Dermatitis—Telmisartan—hypertension	1.6e-05	0.000192	CcSEcCtD
Amphetamine—Diarrhoea—Furosemide—hypertension	1.6e-05	0.000192	CcSEcCtD
Amphetamine—Headache—Telmisartan—hypertension	1.59e-05	0.000191	CcSEcCtD
Amphetamine—Dizziness—Perindopril—hypertension	1.59e-05	0.00019	CcSEcCtD
Amphetamine—Insomnia—Lisinopril—hypertension	1.58e-05	0.00019	CcSEcCtD
Amphetamine—Dizziness—Irbesartan—hypertension	1.58e-05	0.00019	CcSEcCtD
Amphetamine—Diarrhoea—Betaxolol—hypertension	1.58e-05	0.00019	CcSEcCtD
Amphetamine—Gastrointestinal pain—Ramipril—hypertension	1.58e-05	0.000189	CcSEcCtD
Amphetamine—Nausea—Clonidine—hypertension	1.58e-05	0.000189	CcSEcCtD
Amphetamine—Vomiting—Captopril—hypertension	1.57e-05	0.000189	CcSEcCtD
Amphetamine—Dizziness—Hydrochlorothiazide—hypertension	1.57e-05	0.000188	CcSEcCtD
Amphetamine—Dyspnoea—Lisinopril—hypertension	1.56e-05	0.000187	CcSEcCtD
Amphetamine—Rash—Captopril—hypertension	1.56e-05	0.000187	CcSEcCtD
Amphetamine—Dermatitis—Captopril—hypertension	1.56e-05	0.000187	CcSEcCtD
Amphetamine—Somnolence—Lisinopril—hypertension	1.56e-05	0.000187	CcSEcCtD
Amphetamine—Headache—Captopril—hypertension	1.55e-05	0.000186	CcSEcCtD
Amphetamine—Gastrointestinal pain—Timolol—hypertension	1.54e-05	0.000185	CcSEcCtD
Amphetamine—Dizziness—Furosemide—hypertension	1.54e-05	0.000185	CcSEcCtD
Amphetamine—Dyspepsia—Lisinopril—hypertension	1.54e-05	0.000185	CcSEcCtD
Amphetamine—Diarrhoea—Losartan—hypertension	1.54e-05	0.000185	CcSEcCtD
Amphetamine—Nausea—Trandolapril—hypertension	1.54e-05	0.000184	CcSEcCtD
Amphetamine—Urticaria—Ramipril—hypertension	1.53e-05	0.000184	CcSEcCtD
Amphetamine—Nausea—Enalapril—hypertension	1.53e-05	0.000184	CcSEcCtD
Amphetamine—Dizziness—Betaxolol—hypertension	1.53e-05	0.000183	CcSEcCtD
Amphetamine—Vomiting—Perindopril—hypertension	1.53e-05	0.000183	CcSEcCtD
Amphetamine—Abdominal pain—Ramipril—hypertension	1.53e-05	0.000183	CcSEcCtD
Amphetamine—Body temperature increased—Ramipril—hypertension	1.53e-05	0.000183	CcSEcCtD
Amphetamine—Decreased appetite—Lisinopril—hypertension	1.52e-05	0.000183	CcSEcCtD
Amphetamine—Vomiting—Irbesartan—hypertension	1.52e-05	0.000183	CcSEcCtD
Amphetamine—Rash—Perindopril—hypertension	1.51e-05	0.000182	CcSEcCtD
Amphetamine—Dermatitis—Perindopril—hypertension	1.51e-05	0.000181	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Lisinopril—hypertension	1.51e-05	0.000181	CcSEcCtD
Amphetamine—Nausea—Telmisartan—hypertension	1.51e-05	0.000181	CcSEcCtD
Amphetamine—Fatigue—Lisinopril—hypertension	1.51e-05	0.000181	CcSEcCtD
Amphetamine—Vomiting—Hydrochlorothiazide—hypertension	1.51e-05	0.000181	CcSEcCtD
Amphetamine—Rash—Irbesartan—hypertension	1.51e-05	0.000181	CcSEcCtD
Amphetamine—Dermatitis—Irbesartan—hypertension	1.51e-05	0.000181	CcSEcCtD
Amphetamine—Headache—Perindopril—hypertension	1.5e-05	0.00018	CcSEcCtD
Amphetamine—Urticaria—Timolol—hypertension	1.5e-05	0.00018	CcSEcCtD
Amphetamine—Headache—Irbesartan—hypertension	1.5e-05	0.00018	CcSEcCtD
Amphetamine—Constipation—Lisinopril—hypertension	1.5e-05	0.00018	CcSEcCtD
Amphetamine—Rash—Hydrochlorothiazide—hypertension	1.5e-05	0.00018	CcSEcCtD
Amphetamine—Dermatitis—Hydrochlorothiazide—hypertension	1.5e-05	0.000179	CcSEcCtD
Amphetamine—Abdominal pain—Timolol—hypertension	1.49e-05	0.000179	CcSEcCtD
Amphetamine—Body temperature increased—Timolol—hypertension	1.49e-05	0.000179	CcSEcCtD
Amphetamine—Dizziness—Losartan—hypertension	1.49e-05	0.000179	CcSEcCtD
Amphetamine—Headache—Hydrochlorothiazide—hypertension	1.49e-05	0.000178	CcSEcCtD
Amphetamine—Vomiting—Furosemide—hypertension	1.48e-05	0.000178	CcSEcCtD
Amphetamine—Rash—Furosemide—hypertension	1.47e-05	0.000177	CcSEcCtD
Amphetamine—Dermatitis—Furosemide—hypertension	1.47e-05	0.000176	CcSEcCtD
Amphetamine—Vomiting—Betaxolol—hypertension	1.47e-05	0.000176	CcSEcCtD
Amphetamine—Nausea—Captopril—hypertension	1.47e-05	0.000176	CcSEcCtD
Amphetamine—Headache—Furosemide—hypertension	1.46e-05	0.000175	CcSEcCtD
Amphetamine—Rash—Betaxolol—hypertension	1.46e-05	0.000175	CcSEcCtD
Amphetamine—Dermatitis—Betaxolol—hypertension	1.46e-05	0.000175	CcSEcCtD
Amphetamine—Headache—Betaxolol—hypertension	1.45e-05	0.000174	CcSEcCtD
Amphetamine—Gastrointestinal pain—Lisinopril—hypertension	1.43e-05	0.000172	CcSEcCtD
Amphetamine—Vomiting—Losartan—hypertension	1.43e-05	0.000172	CcSEcCtD
Amphetamine—Nausea—Perindopril—hypertension	1.43e-05	0.000171	CcSEcCtD
Amphetamine—Hypersensitivity—Ramipril—hypertension	1.42e-05	0.000171	CcSEcCtD
Amphetamine—Nausea—Irbesartan—hypertension	1.42e-05	0.000171	CcSEcCtD
Amphetamine—Rash—Losartan—hypertension	1.42e-05	0.00017	CcSEcCtD
Amphetamine—Dermatitis—Losartan—hypertension	1.42e-05	0.00017	CcSEcCtD
Amphetamine—Headache—Losartan—hypertension	1.41e-05	0.000169	CcSEcCtD
Amphetamine—Nausea—Hydrochlorothiazide—hypertension	1.41e-05	0.000169	CcSEcCtD
Amphetamine—Urticaria—Lisinopril—hypertension	1.39e-05	0.000167	CcSEcCtD
Amphetamine—Hypersensitivity—Timolol—hypertension	1.39e-05	0.000167	CcSEcCtD
Amphetamine—Nausea—Furosemide—hypertension	1.39e-05	0.000166	CcSEcCtD
Amphetamine—Asthenia—Ramipril—hypertension	1.39e-05	0.000166	CcSEcCtD
Amphetamine—Abdominal pain—Lisinopril—hypertension	1.38e-05	0.000166	CcSEcCtD
Amphetamine—Body temperature increased—Lisinopril—hypertension	1.38e-05	0.000166	CcSEcCtD
Amphetamine—Nausea—Betaxolol—hypertension	1.37e-05	0.000165	CcSEcCtD
Amphetamine—Methamphetamine—SLC6A4—hypertension	1.36e-05	0.00581	CrCbGaD
Amphetamine—Asthenia—Timolol—hypertension	1.35e-05	0.000162	CcSEcCtD
Amphetamine—Nausea—Losartan—hypertension	1.34e-05	0.00016	CcSEcCtD
Amphetamine—Diarrhoea—Ramipril—hypertension	1.32e-05	0.000159	CcSEcCtD
Amphetamine—Diarrhoea—Timolol—hypertension	1.29e-05	0.000155	CcSEcCtD
Amphetamine—Hypersensitivity—Lisinopril—hypertension	1.29e-05	0.000155	CcSEcCtD
Amphetamine—Dizziness—Ramipril—hypertension	1.28e-05	0.000153	CcSEcCtD
Amphetamine—Asthenia—Lisinopril—hypertension	1.26e-05	0.000151	CcSEcCtD
Amphetamine—Dizziness—Timolol—hypertension	1.25e-05	0.00015	CcSEcCtD
Amphetamine—Vomiting—Ramipril—hypertension	1.23e-05	0.000147	CcSEcCtD
Amphetamine—Rash—Ramipril—hypertension	1.22e-05	0.000146	CcSEcCtD
Amphetamine—Dermatitis—Ramipril—hypertension	1.22e-05	0.000146	CcSEcCtD
Amphetamine—Headache—Ramipril—hypertension	1.21e-05	0.000145	CcSEcCtD
Amphetamine—Vomiting—Timolol—hypertension	1.2e-05	0.000144	CcSEcCtD
Amphetamine—Diarrhoea—Lisinopril—hypertension	1.2e-05	0.000144	CcSEcCtD
Amphetamine—Rash—Timolol—hypertension	1.19e-05	0.000143	CcSEcCtD
Amphetamine—Dermatitis—Timolol—hypertension	1.19e-05	0.000143	CcSEcCtD
Amphetamine—Headache—Timolol—hypertension	1.18e-05	0.000142	CcSEcCtD
Amphetamine—Dizziness—Lisinopril—hypertension	1.16e-05	0.000139	CcSEcCtD
Amphetamine—Nausea—Ramipril—hypertension	1.15e-05	0.000138	CcSEcCtD
Amphetamine—Nausea—Timolol—hypertension	1.12e-05	0.000135	CcSEcCtD
Amphetamine—Vomiting—Lisinopril—hypertension	1.11e-05	0.000134	CcSEcCtD
Amphetamine—Rash—Lisinopril—hypertension	1.1e-05	0.000132	CcSEcCtD
Amphetamine—Dermatitis—Lisinopril—hypertension	1.1e-05	0.000132	CcSEcCtD
Amphetamine—Headache—Lisinopril—hypertension	1.1e-05	0.000132	CcSEcCtD
Amphetamine—Nausea—Lisinopril—hypertension	1.04e-05	0.000125	CcSEcCtD
Amphetamine—Nateglinide—ALB—hypertension	8.27e-06	0.00355	CrCbGaD
Amphetamine—CYP2A6—Metabolism—GCG—hypertension	1.64e-06	3.16e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGTR2—hypertension	1.64e-06	3.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OXT—hypertension	1.64e-06	3.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL2—hypertension	1.64e-06	3.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1B—hypertension	1.64e-06	3.15e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—hypertension	1.64e-06	3.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—F2R—hypertension	1.62e-06	3.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFBR1—hypertension	1.62e-06	3.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKCD—hypertension	1.62e-06	3.11e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR5—hypertension	1.62e-06	3.11e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—hypertension	1.61e-06	3.1e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CA9—hypertension	1.6e-06	3.09e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TBXAS1—hypertension	1.6e-06	3.09e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—INS—hypertension	1.6e-06	3.09e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT1—hypertension	1.59e-06	3.06e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—hypertension	1.58e-06	3.05e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—C3—hypertension	1.58e-06	3.04e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NCF1—hypertension	1.57e-06	3.02e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EDNRB—hypertension	1.57e-06	3.02e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALOX5AP—hypertension	1.56e-06	3.01e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALOX15—hypertension	1.56e-06	3.01e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TAC1—hypertension	1.55e-06	2.99e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—STK11—hypertension	1.55e-06	2.97e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP19A1—hypertension	1.55e-06	2.97e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—F2—hypertension	1.53e-06	2.94e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PRKCB—hypertension	1.53e-06	2.94e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LHB—hypertension	1.53e-06	2.94e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HADHA—hypertension	1.53e-06	2.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ANXA1—hypertension	1.52e-06	2.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCR3—hypertension	1.52e-06	2.93e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—hypertension	1.52e-06	2.93e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—hypertension	1.52e-06	2.92e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IKBKB—hypertension	1.51e-06	2.91e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AGT—hypertension	1.5e-06	2.89e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—KCNJ11—hypertension	1.49e-06	2.87e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPA—hypertension	1.49e-06	2.87e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HSD3B2—hypertension	1.49e-06	2.87e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EDNRA—hypertension	1.48e-06	2.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SST—hypertension	1.48e-06	2.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CALM1—hypertension	1.48e-06	2.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB1—hypertension	1.48e-06	2.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CYBA—hypertension	1.48e-06	2.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD3—hypertension	1.48e-06	2.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FLT1—hypertension	1.48e-06	2.84e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—hypertension	1.47e-06	2.83e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRA2A—hypertension	1.45e-06	2.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GHRL—hypertension	1.44e-06	2.78e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLAT—hypertension	1.44e-06	2.78e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—COMT—hypertension	1.44e-06	2.77e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LRP2—hypertension	1.43e-06	2.75e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2C18—hypertension	1.43e-06	2.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALCA—hypertension	1.43e-06	2.75e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GNB3—hypertension	1.42e-06	2.73e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARGC1A—hypertension	1.42e-06	2.73e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMOX1—hypertension	1.41e-06	2.71e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3R1—hypertension	1.41e-06	2.71e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NOS3—hypertension	1.41e-06	2.71e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BDKRB2—hypertension	1.39e-06	2.68e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—hypertension	1.39e-06	2.68e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAT—hypertension	1.39e-06	2.68e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—hypertension	1.39e-06	2.68e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKCB—hypertension	1.39e-06	2.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—F2—hypertension	1.39e-06	2.67e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GNAS—hypertension	1.38e-06	2.65e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRBK1—hypertension	1.38e-06	2.65e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HSPG2—hypertension	1.38e-06	2.65e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR1—hypertension	1.37e-06	2.63e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALM2—hypertension	1.35e-06	2.6e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOB—hypertension	1.35e-06	2.6e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT2—hypertension	1.34e-06	2.57e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR7—hypertension	1.33e-06	2.57e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALOX5—hypertension	1.33e-06	2.56e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GLP1R—hypertension	1.33e-06	2.56e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTEN—hypertension	1.33e-06	2.55e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTPN1—hypertension	1.32e-06	2.54e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GCG—hypertension	1.32e-06	2.54e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTM1—hypertension	1.31e-06	2.53e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH2—hypertension	1.3e-06	2.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KL—hypertension	1.3e-06	2.49e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LPL—hypertension	1.29e-06	2.48e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—hypertension	1.29e-06	2.48e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT1—hypertension	1.28e-06	2.47e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ITGAV—hypertension	1.27e-06	2.45e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NGFR—hypertension	1.27e-06	2.45e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KNG1—hypertension	1.27e-06	2.44e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—EP300—hypertension	1.26e-06	2.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—hypertension	1.26e-06	2.43e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADCY5—hypertension	1.26e-06	2.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRL—hypertension	1.26e-06	2.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGTR1—hypertension	1.26e-06	2.43e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GPX1—hypertension	1.26e-06	2.42e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PRKCA—hypertension	1.25e-06	2.4e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP1A1—hypertension	1.25e-06	2.4e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STK11—hypertension	1.24e-06	2.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HDAC1—hypertension	1.24e-06	2.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL2—hypertension	1.24e-06	2.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL10—hypertension	1.23e-06	2.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLG—hypertension	1.23e-06	2.36e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—RHOA—hypertension	1.23e-06	2.36e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CD36—hypertension	1.23e-06	2.36e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDH2—hypertension	1.22e-06	2.34e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT2—hypertension	1.21e-06	2.34e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3R1—hypertension	1.21e-06	2.34e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB2—hypertension	1.2e-06	2.3e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HBA1—hypertension	1.19e-06	2.28e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCE—hypertension	1.18e-06	2.27e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP11A1—hypertension	1.18e-06	2.27e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDGFA—hypertension	1.17e-06	2.24e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VAV3—hypertension	1.17e-06	2.24e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—hypertension	1.16e-06	2.24e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC9A1—hypertension	1.16e-06	2.23e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTT1—hypertension	1.16e-06	2.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFBR2—hypertension	1.15e-06	2.21e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CETP—hypertension	1.14e-06	2.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCLC—hypertension	1.14e-06	2.2e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARA—hypertension	1.14e-06	2.19e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GNB3—hypertension	1.14e-06	2.19e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AVP—hypertension	1.12e-06	2.16e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTEN—hypertension	1.12e-06	2.16e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—RHOA—hypertension	1.11e-06	2.14e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GNAS—hypertension	1.11e-06	2.13e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AGT—hypertension	1.1e-06	2.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3R1—hypertension	1.1e-06	2.12e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP17A1—hypertension	1.09e-06	2.11e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOB—hypertension	1.09e-06	2.09e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CALM1—hypertension	1.08e-06	2.09e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ENO1—hypertension	1.08e-06	2.09e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS1—hypertension	1.08e-06	2.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTK2—hypertension	1.08e-06	2.08e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOE—hypertension	1.08e-06	2.08e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL8—hypertension	1.08e-06	2.07e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAV1—hypertension	1.07e-06	2.06e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—EP300—hypertension	1.07e-06	2.06e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOA1—hypertension	1.07e-06	2.06e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EDN1—hypertension	1.07e-06	2.06e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL5—hypertension	1.06e-06	2.04e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CTGF—hypertension	1.04e-06	2.01e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LPL—hypertension	1.04e-06	2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMGCR—hypertension	1.03e-06	1.99e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT2—hypertension	1.03e-06	1.99e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—H2AFX—hypertension	1.03e-06	1.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDGFRB—hypertension	1.03e-06	1.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RPS6KB1—hypertension	1.03e-06	1.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADCY5—hypertension	1.01e-06	1.95e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADRA2A—hypertension	1.01e-06	1.95e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCG—hypertension	1.01e-06	1.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCA—hypertension	1e-06	1.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ITGB3—hypertension	1e-06	1.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—YWHAZ—hypertension	9.93e-07	1.91e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NGF—hypertension	9.82e-07	1.89e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SPP1—hypertension	9.82e-07	1.89e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL8—hypertension	9.78e-07	1.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR5—hypertension	9.55e-07	1.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCD—hypertension	9.55e-07	1.84e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TH—hypertension	9.47e-07	1.82e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CALM2—hypertension	9.44e-07	1.82e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—hypertension	9.42e-07	1.81e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—hypertension	9.35e-07	1.8e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—C3—hypertension	9.33e-07	1.8e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—hypertension	9.29e-07	1.79e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—INS—hypertension	9.24e-07	1.78e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC2A4—hypertension	9.22e-07	1.77e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCG—hypertension	9.22e-07	1.77e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDGFB—hypertension	9.09e-07	1.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGFR1—hypertension	9.04e-07	1.74e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT1—hypertension	8.93e-07	1.72e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HIF1A—hypertension	8.9e-07	1.71e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGT—hypertension	8.87e-07	1.71e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALM1—hypertension	8.72e-07	1.68e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOE—hypertension	8.69e-07	1.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LEP—hypertension	8.69e-07	1.67e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—STK11—hypertension	8.67e-07	1.67e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP19A1—hypertension	8.67e-07	1.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CAV1—hypertension	8.61e-07	1.66e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOA1—hypertension	8.59e-07	1.65e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KDR—hypertension	8.51e-07	1.64e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—hypertension	8.47e-07	1.63e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCB—hypertension	8.19e-07	1.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FN1—hypertension	8.19e-07	1.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—F2—hypertension	8.19e-07	1.58e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NOS3—hypertension	8.1e-07	1.56e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3R1—hypertension	8.1e-07	1.56e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—COMT—hypertension	8.06e-07	1.55e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH1—hypertension	8.02e-07	1.54e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARGC1A—hypertension	7.94e-07	1.53e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GNB3—hypertension	7.94e-07	1.53e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMOX1—hypertension	7.91e-07	1.52e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAT—hypertension	7.8e-07	1.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GNAS—hypertension	7.73e-07	1.49e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKT1—hypertension	7.64e-07	1.47e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOB—hypertension	7.57e-07	1.46e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—hypertension	7.47e-07	1.44e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—INS—hypertension	7.42e-07	1.43e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—hypertension	7.41e-07	1.43e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTM1—hypertension	7.37e-07	1.42e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL2—hypertension	7.3e-07	1.41e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPL—hypertension	7.23e-07	1.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1—hypertension	7.18e-07	1.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT2—hypertension	7.18e-07	1.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—EGFR—hypertension	7.15e-07	1.38e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADCY5—hypertension	7.08e-07	1.36e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX1—hypertension	7.06e-07	1.36e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRKCA—hypertension	6.98e-07	1.34e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP1A1—hypertension	6.98e-07	1.34e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CD36—hypertension	6.87e-07	1.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SERPINE1—hypertension	6.82e-07	1.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF2—hypertension	6.6e-07	1.27e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RHOA—hypertension	6.58e-07	1.27e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—hypertension	6.51e-07	1.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOS3—hypertension	6.51e-07	1.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3R1—hypertension	6.51e-07	1.25e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKT1—hypertension	6.47e-07	1.24e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTEN—hypertension	6.46e-07	1.24e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARA—hypertension	6.39e-07	1.23e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AGT—hypertension	6.19e-07	1.19e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—EP300—hypertension	6.16e-07	1.19e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RELA—hypertension	6.13e-07	1.18e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CALM1—hypertension	6.08e-07	1.17e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOE—hypertension	6.06e-07	1.17e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MTOR—hypertension	6.01e-07	1.16e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAV1—hypertension	6.01e-07	1.16e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA1—hypertension	5.99e-07	1.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL8—hypertension	5.77e-07	1.11e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT1—hypertension	5.58e-07	1.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—hypertension	5.49e-07	1.06e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—hypertension	5.28e-07	1.02e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—hypertension	5.22e-07	1.01e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—hypertension	5.21e-07	1e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDKN1A—hypertension	5.2e-07	1e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTEN—hypertension	5.19e-07	1e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—INS—hypertension	5.18e-07	9.97e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK8—hypertension	5.08e-07	9.78e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT1—hypertension	5.07e-07	9.75e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EP300—hypertension	4.95e-07	9.53e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SRC—hypertension	4.82e-07	9.27e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—hypertension	4.75e-07	9.14e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFA—hypertension	4.69e-07	9.03e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NOS3—hypertension	4.54e-07	8.74e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3R1—hypertension	4.54e-07	8.74e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MYC—hypertension	4.32e-07	8.31e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—hypertension	4.3e-07	8.29e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGFR—hypertension	4.22e-07	8.12e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—hypertension	4.15e-07	8e-06	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKT1—hypertension	3.72e-07	7.17e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTEN—hypertension	3.62e-07	6.97e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—hypertension	3.54e-07	6.82e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—EP300—hypertension	3.45e-07	6.65e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—hypertension	3.24e-07	6.24e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT1—hypertension	2.99e-07	5.76e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKT1—hypertension	2.09e-07	4.02e-06	CbGpPWpGaD
